Hangzhou Biotest Biotech Co (SHSE:688767) Operating Cash Flow per Share : ¥0.67 (TTM As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Hangzhou Biotest Biotech Co Operating Cash Flow per Share?

Hangzhou Biotest Biotech Co's operating cash flow per share for the three months ended in Mar. 2025 was ¥0.18. Hangzhou Biotest Biotech Co's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2025 was ¥0.67.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Hangzhou Biotest Biotech Co was -52.10% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -51.10% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 5.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Hangzhou Biotest Biotech Co's Operating Cash Flow per Share or its related term are showing as below:

SHSE:688767' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -51.1 Med: 174.7 Max: 298.4
Current: -51.1

During the past 8 years, Hangzhou Biotest Biotech Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 298.40% per year. The lowest was -51.10% per year. And the median was 174.70% per year.

SHSE:688767's 3-Year OCF Growth Rate is ranked worse than
92.95% of 1219 companies
in the Biotechnology industry
Industry Median: 9.2 vs SHSE:688767: -51.10

Hangzhou Biotest Biotech Co Operating Cash Flow per Share Historical Data

The historical data trend for Hangzhou Biotest Biotech Co's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou Biotest Biotech Co Operating Cash Flow per Share Chart

Hangzhou Biotest Biotech Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Operating Cash Flow per Share

Get a 7-Day Free Trial

3.98

7.49

4.71

0.88

0.87

Hangzhou Biotest Biotech Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Operating Cash Flow per Share	Get a 7-Day Free Trial															0.39	0.25	0.11	0.13	0.18

Competitive Comparison of Hangzhou Biotest Biotech Co's Operating Cash Flow per Share

For the Biotechnology subindustry, Hangzhou Biotest Biotech Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hangzhou Biotest Biotech Co's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hangzhou Biotest Biotech Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Hangzhou Biotest Biotech Co's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Hangzhou Biotest Biotech Co Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Hangzhou Biotest Biotech Co's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (A: Dec. 2024 )	=	Cash Flow from Operations (A: Dec. 2024 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2024 )
	=	128.825	/	147.405
	=	0.87

Hangzhou Biotest Biotech Co's Operating Cash Flow per Share for the quarter that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (Q: Mar. 2025 )	=	Cash Flow from Operations (Q: Mar. 2025 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2025 )
	=	27.573	/	152.818
	=	0.18

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.67

Hangzhou Biotest Biotech Co Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Hangzhou Biotest Biotech Co's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Hangzhou Biotest Biotech Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hangzhou Biotest Biotech Co Ltd (SHSE:688767) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 17, Futai Road, Zhongtai Street, Yuhang District, Zhejiang Province, Hangzhou, CHN, 311121

Website

http://www.biotests.com.cn

Hangzhou Biotest Biotech Co Ltd is engaged in the research and development, manufacturing, sales and service of in vitro diagnostic reagents, raw materials and instruments.

Executives

Gao Hong Mei

Directors, senior managers

Hangzhou Biotest Biotech Co Headlines

No Headlines